Avidity Biosciences, Inc. - COM (RNA)

Historical Portfolio Holders from Q2 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
125M
Holdings value Q3 2024
$5.75B
Value change Q3 2024
+$525M
Grand Portfolio weight change Q3 2024
+0.001%
Number of holders
237
Number of buys Q3 2024
150
Number of sells Q3 2024
-83
Average buys Q3 2024 %
+0.002%
Average sells Q3 2024 %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 125M $5.75B +$525M $45.93 238
2024 Q2 112M $4.57B +$938M $40.85 191
2024 Q1 89.3M $2.28B +$376M $25.52 155
2023 Q4 75.9M $687M -$46.2M $9.05 141
2023 Q3 81.7M $522M -$6.31M $6.38 141
2023 Q2 82.4M $914M +$45.8M $11.09 138
2023 Q1 75.9M $1.16B +$49.8M $15.35 136
2022 Q4 71.6M $1.59B +$426M $22.19 145
2022 Q3 53.4M $872M -$22.2M $16.33 118
2022 Q2 52.1M $758M +$70.6M $14.53 105
2022 Q1 47M $869M +$27M $18.47 96
2021 Q4 45.4M $1.08B +$3.68M $23.77 103
2021 Q3 44.4M $1.09B +$241M $24.63 108
2021 Q2 34.5M $853M +$16.8M $24.71 92
2021 Q1 33.9M $739M +$60.8M $21.81 96
2020 Q4 31M $790M +$74.8M $25.52 82
2020 Q3 27M $755M +$43.8M $28.15 67
2020 Q2 25.5M $702M +$702M $28.26 52